MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...

“The role of testosterone is just a lesson in gender bias,” says Kelly Casperson, MD, a urologist. “Because 100 percent of ...

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...

A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...

The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...